Pricing Log in Create free account

PTC Therapeutics, Inc. (PTCT) vs Scholar Rock Holding Corporation (SRRK)

PTC Therapeutics, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. PTC Therapeutics, Inc. and Scholar Rock Holding Corporation are of similar size ($5.5B and $5.5B). Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against −35.1%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −9.17%) and the lower return on invested capital (0.00% vs 17.7%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 11 and Scholar Rock Holding Corporation on 5.

Valuation

Metric PTCT SRRK Biotechnology median
P/E n/m n/m 10.26
P/S 4.76 125.86 9.18
P/B n/m 23.46 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 32.37 n/m 0.65
EV/Sales 5.37 119.61 8.98
Earnings yield (1.99%) (7.29%) (34.89%)
Free cash flow yield (4.72%) (4.99%) (24.52%)

Profitability

Metric PTCT SRRK Biotechnology median
Gross margin 93.20% 0.00% 65.16%
Operating margin 12.78% 0.00% 0.00%
Net margin (9.17%) 0.00% 0.00%
Free cash flow margin (22.43%) 0.00% 0.00%
Return on equity 61.08% (167.77%) (50.12%)
Return on assets (3.62%) (94.63%) (45.60%)
Return on invested capital 17.66% 0.00% 0.00%

Growth

Metric PTCT SRRK Biotechnology median
Revenue growth (TTM) (35.05%) 213.65% 6.26%
EPS growth (last fiscal year) 264.48% (33.20%) 29.88%
Revenue growth, 5-year CAGR 35.37% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTCT SRRK Biotechnology median
Debt to equity (14.86) 0.77 0.00
Current ratio 3.27 7.02 4.89
Net debt to EBITDA 0.73 0.69 1.01

Dividend

Metric PTCT SRRK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PTCT SRRK Biotechnology median
Market cap 5.49b 5.54b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack